Trygve Holmøy
Position: Postdoctoral researcher
Phone:
Email:

Link to the Research Group on Multiple Sclerosis home page at UiO

 

Author network for Trygve Holmøy by COREMINE medical


Publications 2017

Holmøy T, Lindstrøm JC, Eriksen EF, Steffensen LH, Kampman MT (2017)
High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis - a randomized controlled trial
BMC Neurol, 17 (1), 67
PubMed 28376767

Holmøy T, Torkildsen Ø (2017)
[No title available]
Tidsskr Nor Laegeforen, 137 (4), 259
PubMed 28225223

Holmøy T, von der Lippe H, Leegaard TM (2017)
Listeria monocytogenes infection associated with alemtuzumab - - a case for better preventive strategies
BMC Neurol, 17 (1), 65
PubMed 28376817

Publications 2016

Berge T, Leikfoss IS, Brorson IS, Bos SD, Page CM, Gustavsen MW, Bjølgerud A, Holmøy T, Celius EG, Damoiseaux J, Smolders J, Harbo HF, Spurkland A (2016)
The multiple sclerosis susceptibility genes TAGAP and IL2RA are regulated by vitamin D in CD4+ T cells
Genes Immun, 17 (2), 118-27
PubMed 26765264

Bjørnevik K, Riise T, Bostrom I, Casetta I, Cortese M, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Magalhaes S, Pugliatti M, Wolfson C, Myhr KM (2016)
Negative interaction between smoking and EBV in the risk of multiple sclerosis: The EnvIMS study
Mult Scler, 23 (7), 1018-1024
PubMed 27663872

Holmøy T (2016)
[Not Available]
Tidsskr Nor Laegeforen, 136 (3), 204-5
PubMed 26860374

Holmøy T, Beiske AG, Zarnovicky S, Myro AZ, Røsjø E, Kerty E (2016)
Severe inflammatory disease activity 14 months after cessation of Natalizumab in a patient with Leber's optic neuropathy and multiple sclerosis - a case report
BMC Neurol, 16 (1), 197
PubMed 27756254

Holmøy T, Torkildsen Ø (2016)
Can vitamin D reduce inflammation in relapsing-remitting multiple sclerosis?
Expert Rev Neurother, 16 (3), 233-5
PubMed 26796244

Holmøy T, Torkildsen Ø (2016)
Family planning, pregnancy and breastfeeding in multiple sclerosis
Tidsskr Nor Laegeforen, 136 (20), 1726-1729
PubMed 27830907

Kvistad S, Myhr KM, Holmøy T, Benth JŠ, Løken-Amsrud KI, Wergeland S, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Bakke SJ, Torkildsen Ø (2016)
No association of tobacco use and disease activity in multiple sclerosis
Neurol Neuroimmunol Neuroinflamm, 3 (4), e260
PubMed 27458599

Lossius A, Johansen JN, Vartdal F, Holmøy T (2016)
High-throughput sequencing of immune repertoires in multiple sclerosis
Ann Clin Transl Neurol, 3 (4), 295-306
PubMed 27081660

Nakken O, Lindstrøm JC, Tysnes OB, Holmøy T (2016)
Mortality trends of amyotrophic lateral sclerosis in Norway 1951-2014: an age-period-cohort study
J Neurol, 263 (12), 2378-2385
PubMed 27586392

Nordin A, Akimoto C, Wuolikainen A, Alstermark H, Forsberg K, Baumann P, Pinto S, de Carvalho M, Hübers A, Nordin F, Ludolph AC, Weishaupt JH, Meyer T, Grehl T, Schweikert K, Weber M, Burkhardt C, Neuwirth C, Holmøy T, Morita M, Tysnes OB, Benatar M, Wuu J, Lange DJ, Bisgård C et al. (2016)
Sequence variations in C9orf72 downstream of the hexanucleotide repeat region and its effect on repeat-primed PCR interpretation: a large multinational screening study
Amyotroph Lateral Scler Frontotemporal Degener, 18 (3-4), 256-264
PubMed 27936955

Røsjø E, Lossius A, Abdelmagid N, Lindstrøm JC, Kampman MT, Jørgensen L, Sundström P, Olsson T, Steffensen LH, Torkildsen Ø, Holmøy T (2016)
Effect of high-dose vitamin D3 supplementation on antibody responses against Epstein-Barr virus in relapsing-remitting multiple sclerosis
Mult Scler, 23 (3), 395-402
PubMed 27325604

Simonsen CS, Celius EG, Brunborg C, Tallaksen C, Eriksen EF, Holmøy T, Moen SM (2016)
Bone mineral density in patients with multiple sclerosis, hereditary ataxia or hereditary spastic paraplegia after at least 10 years of disease - a case control study
BMC Neurol, 16 (1), 252
PubMed 27919248

Wergeland S, Myhr KM, Løken-Amsrud KI, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Kvistad SS, Holmøy T, Riise T, Torkildsen Ø (2016)
Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients
Eur J Neurol, 23 (6), 1064-70
PubMed 26998820

Publications 2015

Beiske GA, Holmøy T, Beiske AG, Johannessen SI, Johannessen Landmark C (2015)
Antiepileptic and Antidepressive Polypharmacy in Patients with Multiple Sclerosis
Mult Scler Int, 2015, 317859
PubMed 26221541

Bjørnevik K, Riise T, Cortese M, Holmøy T, Kampman MT, Magalhaes S, Myhr KM, Wolfson C, Pugliatti M (2015)
Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study
Mult Scler, 22 (1), 104-11
PubMed 26014605

Cortese M, Riise T, Bjørnevik K, Holmøy T, Kampman MT, Magalhaes S, Pugliatti M, Wolfson C, Myhr KM (2015)
Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study
Mult Scler, 21 (14), 1856-64
PubMed 25948625

Helland CB, Holmøy T, Gulbrandsen P (2015)
Barriers and Facilitators Related to Rehabilitation Stays in Multiple Sclerosis: A Qualitative Study
Int J MS Care, 17 (3), 122-9
PubMed 26052257

Holmøy T, Esbensen QY, Torkildsen Ø, Wergeland S, Bjerve KS, Beiske AG, Midgard R, Šaltytė-Benth J, Hovdal H, Myhr KM (2015)
WT1 and interferon-β-vitamin D association in MS: a longitudinal study
Acta Neurol Scand, 133 (4), 309-12
PubMed 26037530

Johansen JN, Vartdal F, Desmarais C, Tutturen AE, de Souza GA, Lossius A, Holmøy T (2015)
Intrathecal BCR transcriptome in multiple sclerosis versus other neuroinflammation: Equally diverse and compartmentalized, but more mutated, biased and overlapping with the proteome
Clin Immunol, 160 (2), 211-25
PubMed 26055752

Kvistad SS, Myhr KM, Holmøy T, Šaltytė Benth J, Wergeland S, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Bakke SJ, Michelsen AE, Aukrust P, Ueland T, Sagen JV, Torkildsen Ø (2015)
Body mass index influence interferon-beta treatment response in multiple sclerosis
J Neuroimmunol, 288, 92-7
PubMed 26531700

Lerum SV, Solbraekke KN, Holmøy T, Frich JC (2015)
Unstable terminality: negotiating the meaning of chronicity and terminality in motor neurone disease
Sociol Health Illn, 37 (1), 81-96
PubMed 25601066

Løken-Amsrud KI, Lossius A, Torkildsen Ø, Holmøy T (2015)
Impact of the environment on multiple sclerosis
Tidsskr Nor Laegeforen, 135 (9), 856-60
PubMed 25991624

Magalhaes S, Pugliatti M, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Myhr KM, Parpinel M, Pekmezovic T, Riise T, Wolfson D, Zhu B, Wolfson C (2015)
The EnvIMS Study: Design and Methodology of an International Case-Control Study of Environmental Risk Factors in Multiple Sclerosis
Neuroepidemiology, 44 (3), 173-81
PubMed 25967369

Røsjø E, Myhr KM, Løken-Amsrud KI, Bakke SJ, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Šaltytė Benth J, Torkildsen Ø, Wergeland S, Michelsen AE, Aukrust P, Ueland T, Holmøy T (2015)
Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis
J Neuroimmunol, 280, 21-8
PubMed 25773151

Røsjø E, Steffensen LH, Jørgensen L, Lindstrøm JC, Šaltytė Benth J, Michelsen AE, Aukrust P, Ueland T, Kampman MT, Torkildsen Ø, Holmøy T (2015)
Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis
J Neurol, 262 (12), 2713-21
PubMed 26429571

Publications 2014

Aspli KT, Flaten TP, Roos PM, Holmøy T, Skogholt JH, Aaseth J (2014)
Iron and copper in progressive demyelination--New lessons from Skogholt's disease
J Trace Elem Med Biol, 31, 183-7
PubMed 25563774

Bjørnevik K, Riise T, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Lossius A, Magalhaes S, Myhr KM, Pekmezovic T, Wesnes K, Wolfson C, Pugliatti M (2014)
Sun exposure and multiple sclerosis risk in Norway and Italy: The EnvIMS study
Mult Scler, 20 (8), 1042-9
PubMed 24414538

Geis C, Ritter C, Ruschil C, Weishaupt A, Grünewald B, Stoll G, Holmoy T, Misu T, Fujihara K, Hemmer B, Stadelmann C, Bennett JL, Sommer C, Toyka KV (2014)
The intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer model
Exp Neurol, 265, 8-21
PubMed 25542977

Gulbrandsen P, Ofstad EH, Holmøy T, Vandvik PO (2014)
Shared decision-making in decisions on treatment
Tidsskr Nor Laegeforen, 134 (17), 1670-2
PubMed 25223676

Holmøy T, Løken-Amsrud K, Kampman MT, Torkildsen Ø, Myhr KM (2014)
[Re: Vitamin D--how much is enough, and is more better for your health?]
Tidsskr Nor Laegeforen, 134 (10), 1024-5
PubMed 24865723

Holmøy T, Myhr KM, Bø L (2014)
[Re: Unethical of neurologists not to offer patients with multiple sclerosis chemotherapy with autologous stem cell support]
Tidsskr Nor Laegeforen, 134 (23-24), 2239-40
PubMed 25492327

Kvistad S, Myhr KM, Holmøy T, Bakke S, Beiske AG, Bjerve KS, Hovdal H, Løken-Amsrud KI, Lilleås F, Midgard R, Njølstad G, Pedersen T, Benth JŠ, Wergeland S, Torkildsen O (2014)
Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis
Mult Scler, 20 (14), 1833-40
PubMed 24842958

Lossius A, Johansen JN, Vartdal F, Robins H, Jūratė Šaltytė B, Holmøy T, Olweus J (2014)
High-throughput sequencing of TCR repertoires in multiple sclerosis reveals intrathecal enrichment of EBV-reactive CD8+ T cells
Eur J Immunol, 44 (11), 3439-52
PubMed 25103993

McKenna MJ, Holmøy T (2014)
Approach to bone protection in multiple sclerosis
Eur J Neurol, 22 (4), 601-2
PubMed 24986035

Røsjø E, Myhr KM, Løken-Amsrud KI, Bakke SJ, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JS, Torkildsen Ø, Wergeland S, Michelsen AE, Aukrust P, Ueland T, Holmøy T (2014)
Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis
J Neuroimmunol, 271 (1-2), 60-5
PubMed 24713402

Torkildsen O, Aarseth J, Benjaminsen E, Celius E, Holmøy T, Kampman MT, Løken-Amsrud K, Midgard R, Myhr KM, Riise T, Grytten N (2014)
Month of birth and risk of multiple sclerosis: confounding and adjustments
Ann Clin Transl Neurol, 1 (2), 141-4
PubMed 25356394

Torkildsen O, Aarseth J, Celius EG, Holmøy T, Kampman MT, Løken-Amsrud KI, Midgard R, Myhr KM, Riise T, Grytten N (2014)
Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments
Ann Clin Transl Neurol, 1 (5), 376-7
PubMed 25356407

Vego H, Sand KL, Høglund RA, Fallang LE, Gundersen G, Holmøy T, Maghazachi AA (2014)
Monomethyl fumarate augments NK cell lysis of tumor cells through degranulation and the upregulation of NKp46 and CD107a
Cell Mol Immunol, 13 (1), 57-64
PubMed 25435072

Wesnes K, Riise T, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Lossius A, Magalhaes S, Pekmezovic T, Bjørnevik K, Wolfson C, Pugliatti M, Myhr KM (2014)
Body size and the risk of multiple sclerosis in Norway and Italy: the EnvIMS study
Mult Scler, 21 (4), 388-95
PubMed 25182290

Publications 2013

Holmøy T, Løken-Amsrud KI, Bakke SJ, Beiske AG, Bjerve KS, Hovdal H, Lilleås F, Midgard R, Pedersen T, Saltytė Benth J, Torkildsen O, Wergeland S, Myhr KM, Michelsen AE, Aukrust P, Ueland T (2013)
Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activity
PLoS One, 8 (9), e75021
PubMed 24069377

Høglund RA, Holmøy T, Harbo HF, Maghazachi AA (2013)
A one year follow-up study of natural killer and dendritic cells activities in multiple sclerosis patients receiving glatiramer acetate (GA)
PLoS One, 8 (4), e62237
PubMed 23614042

Kampman MT, Aarseth JH, Grytten N, Benjaminsen E, Celius EG, Dahl OP, Holmøy T, Løken-Amsrud K, Midgard R, Myhr KM, Risberg G, Vatne A, Torkildsen O (2013)
Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway
J Neurol, 260 (6), 1481-8
PubMed 23292231

Lossius A, Riise T, Pugliatti M, Bjørnevik K, Casetta I, Drulovic J, Granieri E, Kampman MT, Landtblom AM, Lauer K, Magalhaes S, Myhr KM, Pekmezovic T, Wesnes K, Wolfson C, Holmøy T (2013)
Season of infectious mononucleosis and risk of multiple sclerosis at different latitudes; the EnvIMS Study
Mult Scler, 20 (6), 669-74
PubMed 24072723

Løken-Amsrud KI, Myhr KM, Bakke SJ, Beiske AG, Bjerve KS, Bjørnarå BT, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JŠ, Torkildsen Ø, Wergeland S, Holmøy T (2013)
Alpha-tocopherol and MRI outcomes in multiple sclerosis--association and prediction
PLoS One, 8 (1), e54417
PubMed 23349882

Torkildsen Ø, Løken-Amsrud KI, Wergeland S, Myhr KM, Holmøy T (2013)
Fat-soluble vitamins as disease modulators in multiple sclerosis
Acta Neurol Scand Suppl (196), 16-23
PubMed 23190287

Publications 2012

Grimaldi L, Barkhof F, Beelke M, Burton J, Holmoy T, Hupperts R, Killestein J, Rieckmann P, Schluep M, Smolders J, SOLAR Study Group (2012)
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis
Neurology, 78 (11), 841
PubMed 22411961

Grytten N, Torkildsen Ø, Aarseth JH, Benjaminsen E, Celius EG, Dahl OP, Holmøy T, Løken-Amsrud K, Midgard R, Myhr KM, Risberg G, Vatne A, Kampman MT (2012)
Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway
Mult Scler, 19 (8), 1028-34
PubMed 23257620

Holmøy T, Hanssen KT, Beiske AG (2012)
Patient satisfaction in rehabilitation of patients with multiple sclerosis
Tidsskr Nor Laegeforen, 132 (5), 523-6
PubMed 22398768

Holmøy T, Kampman MT, Smolders J (2012)
Vitamin D in multiple sclerosis: implications for assessment and treatment
Expert Rev Neurother, 12 (9), 1101-12
PubMed 23039389

Holmøy T, Torkildsen Ø, Myhr KM, Løken-Amsrud KI (2012)
Vitamin D supplementation and monitoring in multiple sclerosis: who, when and wherefore
Acta Neurol Scand Suppl (195), 63-9
PubMed 23278659

Lossius A, Johansen JN, Torkildsen Ø, Vartdal F, Holmøy T (2012)
Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation
Viruses, 4 (12), 3701-30
PubMed 23342374

Løken-Amsrud KI, Holmøy T, Bakke SJ, Beiske AG, Bjerve KS, Bjørnarå BT, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JS, Sandvik L, Torkildsen O, Wergeland S, Myhr KM (2012)
Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment
Neurology, 79 (3), 267-73
PubMed 22700809

Løken-Amsrud KI, Myhr KM, Bakke SJ, Beiske AG, Bjerve KS, Bjørnarå BT, Hovdal H, Lilleås F, Midgard R, Pedersen T, Benth JS, Torkildsen Ø, Wergeland S, Holmøy T (2012)
Retinol levels are associated with magnetic resonance imaging outcomes in multiple sclerosis
Mult Scler, 19 (4), 451-7
PubMed 22907941

Moen SM, Celius EG, Sandvik L, Brustad M, Nordsletten L, Eriksen EF, Holmøy T (2012)
Bone turnover and metabolism in patients with early multiple sclerosis and prevalent bone mass deficit: a population-based case-control study
PLoS One, 7 (9), e45703
PubMed 23029191

Pugliatti M, Casetta I, Drulovic J, Granieri E, Holmøy T, Kampman MT, Landtblom AM, Lauer K, Myhr KM, Parpinel M, Pekmezovic T, Riise T, Zhu B, Wolfson C (2012)
A questionnaire for multinational case-control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q)
Acta Neurol Scand Suppl (195), 43-50
PubMed 23278656

Saltytė Benth J, Myhr KM, Løken-Amsrud KI, Beiske AG, Bjerve KS, Hovdal H, Midgard R, Holmøy T (2012)
Modelling and prediction of 25-hydroxyvitamin D levels in Norwegian relapsing-remitting multiple sclerosis patients
Neuroepidemiology, 39 (2), 84-93
PubMed 22814117

Østern R, Fagerheim T, Ørstavik K, Holmøy T, Heiberg A, Lund-Petersen I, Strom TM, Nilssen Ø, Dahl A (2012)
Hereditary motor neuron disease in a large Norwegian family with a "H46R" substitution in the superoxide dismutase 1 gene
Neuromuscul Disord, 22 (6), 511-21
PubMed 22475618

Publications 2011

Holmøy T (2011)
[Research on low dosage naltrexone]
Tidsskr Nor Laegeforen, 131 (13-14), 1277-8
PubMed 21725378

Holmøy T, Braaten Ø, Hovden IA, Tallaksen CM (2011)
[A young woman with a weakening leg]
Tidsskr Nor Laegeforen, 131 (6), 583-6
PubMed 21423311

Holmøy T, Celius EG (2011)
[Development of new therapies for multiple sclerosis]
Tidsskr Nor Laegeforen, 131 (8), 832-6
PubMed 21556088

Holmøy T, Lossius A, Gundersen TE, Moen SM, Castellazzi M, Fainardi E, Casetta I (2011)
Intrathecal levels of vitamin D and IgG in multiple sclerosis
Acta Neurol Scand, 125 (6), e28-31
PubMed 21781056

Kampman MT, Eriksen EF, Holmøy T (2011)
Multiple sclerosis, a cause of secondary osteoporosis? What is the evidence and what are the clinical implications?
Acta Neurol Scand Suppl (191), 44-9
PubMed 21711256

Lossius A, Vartdal F, Holmøy T (2011)
Vitamin D sensitive EBNA-1 specific T cells in the cerebrospinal fluid of patients with multiple sclerosis
J Neuroimmunol, 240-241, 87-96
PubMed 22018702

Moen SM, Celius EG, Nordsletten L, Holmøy T (2011)
Fractures and falls in patients with newly diagnosed clinically isolated syndrome and multiple sclerosis
Acta Neurol Scand Suppl (191), 79-82
PubMed 21711261

Moen SM, Celius EG, Sandvik L, Nordsletten L, Eriksen EF, Holmøy T (2011)
Low bone mass in newly diagnosed multiple sclerosis and clinically isolated syndrome
Neurology, 77 (2), 151-7
PubMed 21747073

Pandya AD, Al-Jaderi Z, Høglund RA, Holmøy T, Harbo HF, Norgauer J, Maghazachi AA (2011)
Identification of human NK17/NK1 cells
PLoS One, 6 (10), e26780
PubMed 22039549

Smolders J, Hupperts R, Barkhof F, Grimaldi LM, Holmoy T, Killestein J, Rieckmann P, Schluep M, Vieth R, Hostalek U, Ghazi-Visser L, Beelke M, SOLAR study group (2011)
Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial
J Neurol Sci, 311 (1-2), 44-9
PubMed 21620416

Smolders J, Moen SM, Damoiseaux J, Huitinga I, Holmøy T (2011)
Vitamin D in the healthy and inflamed central nervous system: access and function
J Neurol Sci, 311 (1-2), 37-43
PubMed 21862439

Publications 2010

Holmøy T (2010)
[Autoimmune encephalopathy]
Tidsskr Nor Laegeforen, 130 (10), 1043
PubMed 20489808

Holmøy T, Geis C (2010)
The immunological basis for treatment of stiff person syndrome
J Neuroimmunol, 231 (1-2), 55-60
PubMed 20943276

Holmøy T, Harbo HF, Celius EG (2010)
[Treatment of multiple sclerosis]
Tidsskr Nor Laegeforen, 130 (9), 923; author reply 923
PubMed 20453948

Holmøy T, Moen SM (2010)
Assessing vitamin D in the central nervous system
Acta Neurol Scand Suppl (190), 88-92
PubMed 20586743

Holmøy T, Wilson JA, von der Lippe C, Andersen PM, Berg-Hansen P (2010)
G127R: A novel SOD1 mutation associated with rapidly evolving ALS and severe pain syndrome
Amyotroph Lateral Scler, 11 (5), 478-80
PubMed 20192886

Høglund RA, Hestvik AL, Holmøy T, Maghazachi AA (2010)
Expression and functional activity of chemokine receptors in glatiramer acetate-specific T cells isolated from multiple sclerosis patient receiving the drug glatiramer acetate
Hum Immunol, 72 (2), 124-34
PubMed 20977917

Publications 2009

Berg-Hansen P, Vandvik B, Fagerhol M, Holmøy T (2009)
Calprotectin levels in the cerebrospinal fluid reflect disease activity in multiple sclerosis
J Neuroimmunol, 216 (1-2), 98-102
PubMed 19800696

Hestvik AL, Skorstad G, Vartdal F, Holmøy T (2009)
Idiotope-specific CD4(+) T cells induce apoptosis of human oligodendrocytes
J Autoimmun, 32 (2), 125-32
PubMed 19250800

Holmøy T (2009)
[Journalism and ethics]
Tidsskr Nor Laegeforen, 129 (22), 2389
PubMed 19935951

Holmøy T (2009)
The discovery of oligoclonal bands: a 50-year anniversary
Eur Neurol, 62 (5), 311-5
PubMed 19729928

Holmøy T, Førde R (2009)
[The problematic difference]
Tidsskr Nor Laegeforen, 129 (20), 2093
PubMed 19855445

Holmøy T, Harbo H, Vartdal F, Spurkland A (2009)
Genetic and molecular approaches to the immunopathogenesis of multiple sclerosis: an update
Curr Mol Med, 9 (5), 591-611
PubMed 19601809

Holmøy T, Kampman MT (2009)
Alaska, multiple sclerosis, and the vitamin D hypothesis
J Neurol, 257 (2), 305-6
PubMed 19862468

Holmøy T, Moen SM, Gundersen TA, Holick MF, Fainardi E, Castellazzi M, Casetta I (2009)
25-hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis
Mult Scler, 15 (11), 1280-5
PubMed 19808741

Holmøy T, Skorstad G, Hestvik AL, Alvik KM, Vartdal F (2009)
Protective and detrimental immunity: lessons from stiff person syndrome and multiple sclerosis
Acta Neurol Scand Suppl (189), 22-6
PubMed 19566493

Holmøy T, Skorstad G, Røste LS, Scheie D, Alvik K (2009)
Stiff person syndrome associated with lower motor neuron disease and infiltration of cytotoxic T cells in the spinal cord
Clin Neurol Neurosurg, 111 (8), 708-12
PubMed 19616370

Holmøy T, Vartdal F, Hestvik AL, Munthe L, Bogen B (2009)
The idiotype connection: linking infection and multiple sclerosis
Trends Immunol, 31 (2), 56-62
PubMed 19962346

Holmøy T, Aarrestad S, Engstrand P, Ottesen S, Syse A, Førde R (2009)
[Termination of mechanical ventilation in amyotrophic lateral sclerosis]
Tidsskr Nor Laegeforen, 129 (7), 628-31
PubMed 19337331

Skorstad G, Vandvik B, Vartdal F, Holmøy T (2009)
MS and clinically isolated syndromes: shared specificity but diverging clonal patterns of virus-specific IgG antibodies produced in vivo and by CSF B cells in vitro
Eur J Neurol, 16 (10), 1124-9
PubMed 19469834

Publications 2008

Hestvik AL, Skorstad G, Price DA, Vartdal F, Holmoy T (2008)
Multiple sclerosis: glatiramer acetate induces anti-inflammatory T cells in the cerebrospinal fluid
Mult Scler, 14 (6), 749-58
PubMed 18611988

Holmoy T, Celius EG (2008)
Cost-effectiveness of natalizumab in multiple sclerosis
Expert Rev Pharmacoecon Outcomes Res, 8 (1), 11-21
PubMed 20528351

Holmøy T (2008)
Medicine and the arts. Pesta on the Stairs by Theodor Kittelsen. Commentary
Acad Med, 83 (1), 74-5
PubMed 18162756

Holmøy T (2008)
T cells in amyotrophic lateral sclerosis
Eur J Neurol, 15 (4), 360-6
PubMed 18266871

Holmøy T (2008)
The immunology of multiple sclerosis: disease mechanisms and therapeutic targets
Minerva Med, 99 (2), 119-40
PubMed 18431322

Holmøy T, Hestvik AL (2008)
Multiple sclerosis: immunopathogenesis and controversies in defining the cause
Curr Opin Infect Dis, 21 (3), 271-8
PubMed 18448972

Pugliatti M, Harbo HF, Holmøy T, Kampman MT, Myhr KM, Riise T, Wolfson C (2008)
Environmental risk factors in multiple sclerosis
Acta Neurol Scand Suppl, 188, 34-40
PubMed 18439219

Skorstad G, Hestvik AL, Torjesen P, Alvik K, Vartdal F, Vandvik B, Holmøy T (2008)
GAD65 IgG autoantibodies in stiff person syndrome: clonality, avidity and persistence
Eur J Neurol, 15 (9), 973-80
PubMed 18637036

Skorstad G, Hestvik AL, Vartdal F, Holmøy T (2008)
Cerebrospinal fluid T cell responses against glutamic acid decarboxylase 65 in patients with stiff person syndrome
J Autoimmun, 32 (1), 24-32
PubMed 19027267

Publications 2007

Frich JC, Holmoy T (2007)
Rowing without oars [Excerpt] - Commentary
Acad. Med., 82 (6), 595

Frich JC, Holmøy T (2007)
Medicine and the arts. Rowing without Oars [excerpt] by Ulla-Carin Lindquist. Commentary
Acad Med, 82 (6), 594-5
PubMed 17525548

Hestvik AL, Vartdal F, Fredriksen AB, Thompson KM, Kvale EO, Skorstad G, Bogen B, Holmoy T (2007)
T cells from multiple sclerosis patients recognize multiple epitopes on Self-IgG
Scand J Immunol, 66 (4), 393-401
PubMed 17850583

Holmøy T (2007)
[Knowledge, association capacity and drowsiness]
Tidsskr Nor Laegeforen, 127 (23), 3088
PubMed 18098377

Holmøy T (2007)
Immunopathogenesis of multiple sclerosis: concepts and controversies
Acta Neurol Scand Suppl, 187, 39-45
PubMed 17419827

Holmøy T (2007)
Vitamin D status modulates the immune response to Epstein Barr virus: Synergistic effect of risk factors in multiple sclerosis
Med Hypotheses, 70 (1), 66-9
PubMed 17574770

Holmøy T (2007)
Long-term effect of gabapentin in stiff limb syndrome: a case report
Eur Neurol, 58 (4), 251-2
PubMed 17851249

Holmøy T, Bjørgo K, Roos PM (2007)
Slowly progressing amyotrophic lateral sclerosis caused by H46R SOD1 mutation
Eur Neurol, 58 (1), 57-8
PubMed 17483589

Holmøy T, Celius EG (2007)
[Incorrect information about treatment of multiple sclerosis from the Knowledge Center]
Tidsskr Nor Laegeforen, 127 (12), 1672-3; author reply 1673
PubMed 17571115

Holmøy T, Celius EG (2007)
[A rush job and knowledge handling]
Tidsskr Nor Laegeforen, 127 (15), 1961-2
PubMed 17700745

Holmøy T, Horn MA, Vandvik B (2007)
[A stiff-legged man with a bizarre gait]
Tidsskr Nor Laegeforen, 127 (11), 1529-30
PubMed 17566229

Holmøy T, Nakstad PH, Fredø HL, Kumar T (2007)
Intravascular large B-cell lymphoma presenting as cerebellar and cerebral infarction
Arch Neurol, 64 (5), 754-5
PubMed 17502477

Holmøy T, Vartdal F (2007)
The immunological basis for treatment of multiple sclerosis
Scand J Immunol, 66 (4), 374-82
PubMed 17850581

Smestad C, Sandvik L, Holmoy T, Harbo HF, Celius EG (2007)
Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway
J Neurol, 255 (1), 49-55
PubMed 18080855

Publications 2006

Holmøy T (2006)
A Norse contribution to the history of neurological diseases
Eur Neurol, 55 (1), 57-8
PubMed 16479124

Holmøy T, Frich JC (2006)
[Stories about life with amyotrophic lateral sclerosis]
Tidsskr Nor Laegeforen, 126 (24), 3297-9
PubMed 17170792

Holmøy T, Hestvik AL, Vartdal F (2006)
Towards individualised multiple sclerosis treatment
Lancet Neurol, 5 (2), 111-2
PubMed 16426986

Holmøy T, Hestvik AL, Vartdal F (2006)
Management of progressive multifocal leukoencephalopathy associated with natalizumab--possibilities and responsibility
Eur J Neurol, 13 (8), e2
PubMed 16879280

Holmøy T, Philip AA (2006)
Medicine and the arts. Three Elling Solheim poems translated by Alison Arderne Philip. Commentary
Acad Med, 81 (5), 474-5
PubMed 16639206

Holmøy T, Roos PM, Kvale EØ (2006)
ALS: cytokine profile in cerebrospinal fluid T-cell clones
Amyotroph Lateral Scler, 7 (3), 183-6
PubMed 16963408

Holmøy T, Worren T (2006)
[Communication aids in amyotrophic lateral sclerosis]
Tidsskr Nor Laegeforen, 126 (19), 2523-5
PubMed 17028633

Leirvik A, Liverød M, Holmøy T (2006)
[Quality of life of patients with amyotrophic lateral sclerosis]
Tidsskr Nor Laegeforen, 126 (19), 2520-2
PubMed 17028632

Publications 2005

Holmøy T, Fredriksen AB, Thompson KM, Hestvik AL, Bogen B, Vartdal F (2005)
Cerebrospinal fluid T cell clones from patients with multiple sclerosis: recognition of idiotopes on monoclonal IgG secreted by autologous cerebrospinal fluid B cells
Eur J Immunol, 35 (6), 1786-94
PubMed 15864781

Holmøy T, Vartdal F (2005)
Infectious causes of multiple sclerosis
Lancet Neurol, 4 (5), 268; discussion 269
PubMed 15847838

Publications 2004

Holmøy T, Kvale EØ, Vartdal F (2004)
Cerebrospinal fluid CD4+ T cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein
J Neurovirol, 10 (5), 278-83
PubMed 15385250

Holmøy T, Vartdal F (2004)
Cerebrospinal fluid T cells from multiple sclerosis patients recognize autologous Epstein-Barr virus-transformed B cells
J Neurovirol, 10 (1), 52-6
PubMed 14982728

Publications 2003

Holmøy T, Vandvik B, Vartdal F (2003)
T cells from multiple sclerosis patients recognize immunoglobulin G from cerebrospinal fluid
Mult Scler, 9 (3), 228-34
PubMed 12814167

Publications 1999

Holmøy T, Berg-Johnsen J, Magnaes B (1999)
[Early postoperative complications in carotid surgery]
Tidsskr Nor Laegeforen, 119 (7), 922-4
PubMed 10210950

Publications 1996

Holmøy T, Sandberg L (1996)
[Painless femoral neck fracture in a patient with multiple sclerosis]
Tidsskr Nor Laegeforen, 116 (2), 249
PubMed 8633335

Publications 1994

Solberg AG, Holmøy T (1994)
[Information--most of the patients are satisfied]
Tidsskr Nor Laegeforen, 114 (8), 988
PubMed 8191481

Publications 1993

Holmøy T (1993)
[Cerebellar infarctions]
Tidsskr Nor Laegeforen, 113 (20), 2564-5
PubMed 8236175